
- News
- Meetings
Welcome to PharmaCircle™
PharmaCircle™'s comprehensive product & pipeline information (research phase to marketed) from 4577 companies around the globe is searchable for every imaginable details (phase, indication, route, partnerships, molecule type, mechanism, delivery route, dose, administration, exclusivity, pharmacokinetic and physical chemical properties of molecules). Search results are downloadable to Excel tables or can be visualized in 2-D and 3-D charts.

PharmaCircle™ have up-to-date detailed profile of nearly 7906 pharma/bio, specialty pharma, drug delivery, generic, pharma services and venture capital companies around the globe. See the demo for more details!
| Number of Companies vs. Business Type | |||
pharma/bio pharmaceutical ser. drug delivery specialty pharma |
| ||
| Number of Companies | |||
| Abbreviation Keys: pharmaceutical ser.:pharmaceutical services | |||
World's most comprehensive Drug Delivery information and analysis: With 3408 DD technologies by 1048 companies and 18937 pipeline&products in 209 DD categories, 25 expert written review articles and 35 compare and contrast tables for technologies in every major DD categories facilitates technology & product decisions and licensing, due diligence and competitive intelligence.

FDA product information service integrates most sought out content from Drugs@FDA (approval package/history, dosage forms, companies, therapeutic equivalents), Electronic Orange Book (market and patent exclusivity), NDC (packaging info), excipient data base (amount of excipients used in each dosage form), Product Labels (non-PDF labels).
- News
- FDA US Labels
- FDA Products
- Excipients
Top 100 Drug Sales - 2009
| Product | world(M$) | Change | |
| 1 | Lipitor Tablets | 12651.0 | 2.0% |
| 2 | Plavix Tablets | 9493.0 | 4.0% |
| 3 | Advair Diskus Group | 7792.3 | 4.4% |
| 4 | Enbrel Group | 6067.0 | -1.0% |
| 5 | Diovan Tablets Group | 6013.0 | 4.5% |
| 6 | AVASTIN Injection | 5745.1 | 18.4% |

PharmaCircle has investment profile of 1115 investors and 2129 invested companies in Pharma/Bio and drug delivery. The product and pipeline therapeutic categories and the drug delivery routes of investments are provided as tables and charts.



